ArticleBreast cancer research : BCR2012

Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.

Marion T Weigel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.